Claus Roehrborn

Claus Roehrborn, MD, is a world-renowned urologist and Chair of the Department of Urology at UT Southwestern Medical Center since 2002. His clinical expertise encompasses prostate cancer and benign prostatic hyperplasia (BPH), with a focus on minimally invasive treatments. Under his leadership, the department has consistently ranked among the nation's best by U.S. News & World Report.

• Education: Medical degree from Justus Liebig University in Giessen, West Germany

Dr. Roehrborn’s research spans prostate biology, robotic surgery, and novel therapies for BPH, including Aquablation, Urolift, and Rezum water vapor therapy. His work emphasizes improved patient outcomes, precision medicine, and healthcare utilization. He has authored over 30 publications, primarily on LUTS and BPH, with recent studies focusing on long-term efficacy and comparative treatment analysis.

His 2024-2025 articles highlight trends in minimally invasive therapies, patient selection models, and quality-of-life metrics. Notable studies include the WATER trials comparing Aquablation to TURP and evaluations of Urolift and Rezum in controlled trials.

• Scientific Awards:
  • Patricia and William L. Watson, Jr., M.D. Award for Excellence in Clinical Medicine (2010)
  • Eugene Fuller Triennial Prostate Award (2022, American Urological Association)

Dr. Roehrborn has been instrumental in developing clinical guidelines for BPH management since 1994 and pioneered the robotic surgery program at UT Southwestern in 2006, performing over 3,000 da Vinci prostatectomies. His work bridges bench-to-bedside research, translating pharmacological and surgical innovations into clinical practice.